Merge Healthcare (NASDAQ:MRGE) will be releasing its Q114 earnings data on Tuesday, April 28th. Analysts expect Merge Healthcare to post earnings of $0.04 per share and revenue of $56.18 million for the quarter.
Merge Healthcare (NASDAQ:MRGE) last released its earnings data on Wednesday, February 25th. The company reported $0.05 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.04 by $0.01. On average, analysts expect Merge Healthcare to post $0.21 EPS for the current fiscal year and $0.25 EPS for the next fiscal year.
Merge Healthcare (NASDAQ:MRGE) opened at 6.04 on Friday. Merge Healthcare has a one year low of $1.97 and a one year high of $6.20. The stock has a 50-day moving average of $4. and a 200-day moving average of $3.. The company’s market cap is $582.85 million.
MRGE has been the subject of a number of recent research reports. Analysts at Robert W. Baird initiated coverage on shares of Merge Healthcare in a research note on Thursday, March 19th. They set an “outperform” rating and a $5.00 price target on the stock. Analysts at Topeka Capital Markets raised their price target on shares of Merge Healthcare from $4.50 to $5.25 and gave the company a “buy” rating in a research note on Monday, March 16th. Finally, analysts at Zacks reiterated a “neutral” rating and set a $4.25 price target on shares of Merge Healthcare in a research note on Tuesday, March 10th.
Merge Healthcare Incorporated (NASDAQ:MRGE) develops software solutions that facilitate the sharing of images to create an electronic healthcare experience for patients and physicians. Its solutions are designed to help solve some of the challenges in health information exchange, such as the incorporation of medical images and diagnostic information into broader health information technology (IT) applications and the interoperability of software solutions.
